Evaluation of solid lipid nanoparticles as carriers for delivery of hepatitis b surface antigen for vaccination using subcutaneous route

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 13, Issue 4, 2010, Pages 495-509

  Mishra, Himanshu ^a   Mishra, Dinesh ^b   Mishra, Pradyumna K ^c   Nahar, Manoj ^a   Dubey, Vaibhav ^a   Jain, Narendra K ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b Mahakal Institute of Pharmaceutical Studies   (India)

^c TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 2; SOLID LIPID NANOPARTICLE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DISPERSION; DRUG CYTOTOXICITY; DRUG DOSAGE FORM COMPARISON; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; INTERNALIZATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; NONHUMAN; PARTICLE SIZE; SURFACE PROPERTY; TH1 CELL; TH2 CELL; X RAY DIFFRACTION; ZETA POTENTIAL;

EID: 78650336277     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3xk53     Document Type: Article

References (26)

1. Foged C, Sundblad A, Hovgaard L. Targeting vaccines to dendritic cells. Pharm Res, 2002;19: 229-238.
2. Gutierro I, Hernández RM, Igartua M, Gascón AR, Pedraz JL. Influence of dose and immunization route on the serum IgG antibody response to BSA loaded PLGA microspheres. Vaccine, 2002; 20: 2181-2190.
3. Oussoren C, Storm G. Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Del Rev, 2001; 50: 143-156.
4. Porter CJH, Edwards GA, Charman SA. Lymphatic transport of proteins after s.c. injection: implications of animal model selection. Adv Drug Del Rev, 2001; 50: 157-171.
5. Almeida AJ, Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Del Rev, 2007; 59: 478-490.
6. Gualbert J, Shahgaldian P, Coleman AW. Interactions of amphiphilic calyx [4] arene-based solid lipid nanoparticles with bovine serum albumin. Int J pharm, 2003; 257: 69-73.
7. Davis HL, Millan CLB. DNA-based immunization against hepatitis B virus. Springer Semin Immunopathol, 1997; 19: 195-209.
8. Schubert MA, Muller-Goymann CC. Solvent injection as a new approach for manufacturing lipid nanoparticles-evaluation of the method and process parameters. Eur J Pharm Biopharm, 2003; 55: 125-131.
9. Saraf S, Mishra D, Asthana A, Jain R, Singh S, Jain NK. Lipid microparticles for mucosal immunization against Hepatitis B. Vaccine, 2006; 24: 45-56.
10. Bot AI, Smith DJ, Bot S, Dellamary L, Tarara TE, Harders S, et al. Receptor-mediated targeting of spray-dried lipid particles coformulated with immunoglobulin and loaded with a prototype vaccine. Pharm Res, 2001; 18: 971-979.
11. Wang L, Bot S, Smith D, Guo GR, Philips B, Dellamary L, et al. Basic immunological properties of spray dried lipid microparticles developed for nasal and systemic administration of vaccine. STP Pharm Sci, 2002; 12: 53-61.
12. Mishra D, Mishra PK, Dabadghao S, Dubey V, Nahar M, Jain NK. Comparative evaluation of hepatitis B surface antigen-loaded elastic liposomes and ethosomes for human dendritic cell uptake and immune response. Nanomedicine, 2010; 6: 110-118.
13. Foged C, Arigita C, Sundblad A, Jiskoot W, Storm G, FroKjaer S. Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition. Vaccine, 2004; 22: 1903-1913.
14. Mishra D, Mishra PK, Dubey V, Dabadghao S, Jain NK. Evaluation of uptake and generation of immune response by murine dendritic cells pulsed with hepatitis B surface antigen-loaded elastic liposomes. Vaccine, 2007; 25: 6939-6944.
15. Mishra D, Mishra PK, Dubey V, Nahar M, Dabadghao S, Jain NK. Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen loaded modified liposomes. Eur J Pharm Sci, 2008; 33: 424-433.
16. Huth US, Schubert R, Peschka-Suss R. Investigating the uptake and intracellular fate of pH-sensitive liposomes by flow cytometry and spectral bioimaging. J Control Rel, 2006; 110: 490-504.
17. Roche Diagnostics Corporation, Apoptosis, cell death and proliferation, 3rd Edition 2004/2005, 2006.
18. Wang S, Liu X, Fisher K, Smith JG, Chen F, Tobery TW, et al. Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium or aluminium phosphate. Vaccine, 2000;18:1227-1235.
19. Mishra D, Dubey V, Asthana A, Saraf DK, Jain NK. Elastic liposomes mediated transcutaneous immunization against hepatitis B. Vaccine, 2006; 24: 4847-4855.
20. Esposito E, Fantin M, Marti M, Drechsler M, Paccamiccio L, Mariani P, et al. Solid lipid nanoparticles as delivery systems for bromocriptine. Pharm Res, 2008; 25: 1521-1530.
21. Quintanar-Guerrero D, Allemann E, Doelker E, Fessi H. A mechanistic study of the formulation of polymer nanoparticles by the emulsification diffusion technique. Colloid Polym Sci, 1997; 275: 640-647.
22. Yan C, Resau JH, Hewetson J, West M, Rill WL, Kende M. Characterization and morphological analysis of protein loaded poly- (lactide coglycolide) microparticle prepared by water in oil in water emulsion technique. J Control Rel, 1994; 32: 231-241.
23. Mehnert W, Mader K. Solid lipid nanoparticles production, characterization and applications. Adv Drug Deliv Rev, 2001; 47: 165-196.
24. Chapman D. The polymorphism of glycerides. Chem Rev, 1962; 62: 433-56.
25. Heuetault B, Saulnier P, Pech B, Proust JE, Benoit JP. Physico-chemical stability of colloidal lipid particles. Biomaterials, 2003; 24: 4283-4300.
26. Freitas C, Muller RH. Spray-drying of solid lipid nanoparticles (SLN TM), Eur J Pharm Biopharm, 1998; 46: 145-151.